Janux Therapeutics Inc. (JANX)

JANX trades at $24, 4.0% below the near-term max pain of $25 expiring Oct 17, 2025 (12 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($8-$30), reflecting growing call interest at higher strikes. Key magnetic zone at 25 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for JANX shows an upward trend from 8 to 30, suggesting bullish positioning in longer-dated options. The 101% spread signals divergent expectations across timeframes. Levels distributed around 24. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.